ELDN Earnings

Quarterly EPS
$-0.60
Q4 2024
$-0.08
Q1 2025
$-0.13
Q2 2025
$-0.21
Q3 2025
$-0.14
Q4 2025
$-0.33
Q1 2026
$-0.27
Q2 2026
$-0.03
Q3 2026
Latest RevenueN/A
Latest Net Income-3933000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.030-3933000—+85.7%
Q2 2026-$0.270-31630000—-107.7%
Q1 2026-$0.330-39025000—-312.5%
Q4 2025-$0.140-10447000—+76.7%
Q3 2025-$0.210-17459000—-120.0%
Q2 2025-$0.130-11216000—+85.9%
Q1 2025-$0.080-6495000—+76.5%
Q4 2024-$0.600-44617000—+40.0%
Q3 2024$1.05077.0M——
Q2 2024-$0.920-44907000——
Q1 2024-$0.340-10869000——
Q4 2023-$1.000-30099000——
Eledon Pharmaceuticals (ELDN) — Earnings